PhD Tim Božič

PhD Tim Božič
no.: 51848 source: ARIS

researcher – active in research organisation
Edit
Research activity

Code Science Field Subfield
3.00.00  Medical sciences     
3.04.00  Medical sciences  Oncology   
Bibliography Representative bibliographic units | Personal | COBISS+
source: COBISS
source: SICRIS
Evaluation (metodology)
Evaluation of bibliographic research performance indicators according to ARIS methodology
source: COBISS
source: ARIS
Points
367.23
A''
31.37
A'
223.84
A1/2
284.7
CI10
71
CImax
11
h10
5
A1
1.34
A3
1.94
Data for the last 5 years (citations for the last 10 years) on September 16, 2026; Data for score A3 calculation refer to period 2021-2025 (2022, 2023, 2024)
Data for ARIS tenders ( 21.05.2024 – Target research programmes, archive )
Citations Citations for bibliographic records in COBIB.SI that are linked to records in citation databases
source: WoS source: Scopus source: COBISS
Database Linked records Citations Pure citations Average pure citations
WoS 18  73  53  2.94 
Scopus 21  99  71  3.38 
Doctoral dissertations and other final papers Show
Obtaining results now
source: COBISS
Employments
source: ARIS
Type of employment Research org. Research group
Full time employment (30%, RD:30%)  Institute of Oncology Ljubljana  Department of research 
Research projects Legend
source: ARIS
no. Code Title Period Head of the Last Period
1. L3-70150  Triad of Precision: A Synergistic 3dCAR-MSC Platform Targeting Melanoma via Immune Activation, TRAIL-induced Apoptosis, and PD-L1 Identification/Blockade   3/1/2026 - 2/28/2029  PhD Urban Švajger   2,608 
2. J7-4635  MitoCan - Preclinical development of new Mitochondrial ion channel inhibitors for Cancer therapy   10/1/2022 - 9/30/2026  PhD Lucija Peterlin Mašič   7,133 
3. Z3-50112  Irradiation and trained immunity: The role of NK cells   10/1/2023 - 5/31/2026  PhD Tim Božič   111 
4. L7-4491  Development of integrated multi-channel artificial nose for detection of cancer   10/1/2022 - 9/30/2025  PhD Igor Muševič   6,283 
5. J3-3083  Vascularization and vascular effects as predictive factors for local ablative techniques   10/1/2021 - 9/30/2025  PhD Gregor Serša   7,804 
6. J3-3084  Inducible Programming of CAR T Cell Intrinsic Properties for Cancer Immunotherapy   10/1/2021 - 12/31/2024  PhD Anže Smole   3,065 
7. J3-2528  Immuno gene electrotransfer of IL-12 and IL-2 in immunologically cold/hot tumors   9/1/2020 - 8/31/2023  PhD Maja Čemažar   3,648 
8. J3-2529  Role of endothelium in tumor response to radiotherapy   9/1/2020 - 8/31/2023  PhD Boštjan Markelc   3,991 
ARIS research and infrastructure programmes Legend
source: ARIS
no. Code Title Period Head of the Last Period
1. P3-0428  Comparative oncology for tackling rare cancers   1/1/2022 - 12/31/2027 PhD Ario de Marco   1,198 
2. P3-0003  Development and evaluation of new approaches to cancer treatment   1/1/2022 - 12/31/2027 PhD Maja Čemažar   4,744 
3. P3-0003  Development and evaluation of new approaches to cancer treatment   1/1/2015 - 12/31/2021 PhD Gregor Serša   3,771 
We were not given permission by the researcher to publish data.
Confirmation required
Views history
Favourite